Case Series
Clinical Characteristics and Treatment Outcomes in Endogenous Cushing’s Syndrome: A 15-Year Experience from Thailand
Table 3
Clinical characteristics of patients according to different subtypes of CS.
| | Features | CD (n = 45) | Adrenal CS (n = 26) | EAS (n = 11) | value |
| | Age (years) | 33 (28–43) | 40 (29–53) | 48 (45–64) | 0.003 | | Female (n, %) | 37 (82) | 22 (85) | 7 (64) | 0.308 | | Onset of symptoms (months) | 12 (7–24) | 12 (5–24) | 7 (3–12) | 0.427 | | Hypertension (n, %) | 29 (64) | 20 (77) | 7 (64) | 0.519 | | DM (n, %) | 14 (31) | 7 (27) | 3 (27) | 0.921 | | VTE (n, %) | 1 (2) | 1 (4) | 2 (18) | 0.085 | | Hypokalemia (n, %) | 9 (20) | 9 (35) | 5 (45) | 0.149 | | Morning cortisol (nmol/L) | 690 (497–828) | 690 (469–745) | 1269 (1131–1738) | 0.052 | | UFC (nmol/day) | 1593 (759–2616) | 378 (113–1673) | 3003 (2089–13794) | 0.013 | | Follow-up time (months) | 42 (18–75) | 32 (11–57) | 5 (2–65) | 0.174 |
|
|
Data were expressed in median (interquartile range). CS, Cushing’s syndrome; CD, Cushing’s disease; EAS, ectopic ACTH syndrome; DM, diabetes mellitus; VTE, venous thromboembolism; UFC, urinary free cortisol.
|
